Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring and Linkage with Clinical Registry Data: Randomised Clinical Trial in Patients with Lung Cancer
University of Bayreuth
220 participants
Feb 15, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.
Eligibility
Inclusion Criteria4
- primary diagnosis of lung cancer (ICD C33/C34, all stages)
- treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospital Bamberg);
- difference between date of histology and date of study entry not exceeding 2 months;
- informed consent;
Exclusion Criteria8
- unavailability of a study clinician for patient recruitment;
- patient misclassified in the candidate list (no primary diagnosis, no lung tumour);
- coordinating practitioner refuses trial participation;
- patient outside the defined study region (Germany, Bavaria: Upper Palatinate, Lower Bavaria, Upper Franconia);
- age under 18 years;
- pregnancy/ breastfeeding;
- patient unable to fill out the QoL questionnaire (physical, psychological, cognitive, language reasons);
- patient refuses trial participation
Interventions
Electronic QoL monitoring including QoL diagnosis and therapy (pain therapy, psychotherapy, social support, nutrition, physiotherapy, fitness, respiratory counselling, palliative care). Patients and treating physicians have access to the results of their QoL monitoring and to a network of local healthcare providers.
Electronic QoL monitoring without QoL diagnosis and therapy. Patients and treating physicians have no access to the results of their QoL monitoring. The therapist network is also available for control arm.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06252233